Have any questions? 706-721-6582 or cts@augusta.edu
- MS200647_0046 Safety Study of Bintrafusp alfa in Combination with Other Anti-cancer Therapies in Participants with Locally Advanced or Advanced Cervical Cancer
Clinical Trial
MS200647_0046 Safety Study of Bintrafusp alfa in Combination with Other Anti-cancer Therapies in Participants with Locally Advanced or Advanced Cervical Cancer
The purpose of this study is to discover or verify whether the medication works in a specific disease state and how safe it is. Clinical research is done in several phases. This is a Phase !b safety study in which the study drug is being tested for safety in combination with other commonly used treatments (chemotherapy) for your type of cancer.
Eligibility Criteria
- Participants must be at least 18 years of age.Must have persistent, recurrent, or metastatic squamous celll carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix. Must not have any significant or chronic infections.
RESEARCH. INNOVATION. DISCOVERY.